Cristian Conti

Cristian Conti

Auto-generated profile, based on publicly available information

Cristian Conti

Division of General and Hepatobiliary Surgery, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

19 January 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
Giulia TurriGiulia Turri
Giulia Turri
Valeria BarresiValeria Barresi
Valeria Barresi
AVAlessandro Valdegamberi
Alessandro Valdegamberi
GGGabriele Gecchele
Gabriele Gecchele
CCCristian Conti
Cristian Conti
Corrado PedrazzaniCorrado Pedrazzani
Corrado Pedrazzani
Although stage I and II colon cancers (CC) generally show a very good prognosis, a small proportion of these patients dies from recurrent disease. The identification of high-risk patients, who may benefit from adjuvant chemotherapy, becomes therefore essential. We retrospectively evaluated 107 cases of stage I (n = 28, 26.2%) and II (n = 79, 73.8%) CC for correlations among preoperative inflammatory markers, histopathological factors and long-term prognosis. A neutrophil-to-lymphocyte ratio greater than 3 (H-NLR) and a platelet-to-lymphocyte ratio greater than 150 (H-PLR) were significantly associated with the presence of poorly differentiated clusters (PDC) (p = 0.007 and p = 0.039, respectively). In addition, H-NLR and PDC proved to be significant and independent survival prognosticators for overall survival (OS; p = 0.007 and p < 0.001, respectively), while PDC was the only significant prognostic factor for cancer-specific survival (CSS; p < 0.001,). Finally, the combination of H-NLR and PDC allowed an optimal stratification of OS and CSS in our cohort, suggesting a potential role in clinical practice for the identification of high-risk patients with stage I and II CC.

2 April 2019 in Clinical and Translational Oncology
Verified
Journal Article
Closed access
PDF file
Corrado PedrazzaniCorrado Pedrazzani
Corrado Pedrazzani
Giulia TurriGiulia Turri
Giulia Turri
GMG. Mantovani
G. Mantovani
CCC. Conti
C. Conti
RZR. Ziello
R. Ziello
AGA. Guglielmi
A. Guglielmi

22 November 2022 in Trials
Verified
Journal Article
Open access
PDF file
Corrado PedrazzaniCorrado Pedrazzani
Corrado Pedrazzani
IMIsacco Montroni
Isacco Montroni
CCCristian Conti
Cristian Conti
Giulia TurriGiulia Turri
Giulia Turri
CFCaterina Foppa
Caterina Foppa
ASAntonino Spinelli
Antonino Spinelli
Background: Enhanced Recovery After Surgery (ERAS) represents the standard of care in colorectal surgery. Among ERAS items, early removal of urinary catheter (UC) is considered a key issue, though adherence to this specific item still varies among centers. UC placement allows for monitoring of post-operative urinary output but relates to an increased risk of urinary tract infection (UTI), reduced mobility, and patient’s discomfort. Several studies investigated the role of early UC removal specifically looking at the rate of acute urinary retention (AUR) but most of them were retrospective, single-center, underpowered, cohort studies. The main purpose of this study is to compare the rate of AUR after immediate (at the end of the surgery) versus early (within 24 h from the completion of surgery) removal of UC in patients undergoing minimally invasive colonic resection (MICR). The secondary outcomes focus on goals that could be positively impacted by the immediate removal of the UC at the end of the surgery. In particular, the rate of UTIs, perception of pain, time-to-return of bowel and physical functions, postoperative complications, and length of hospital stay will be measured. Methods: This is a prospective, randomized, controlled, two-arm, multi-center, study comparing the rate of AUR after immediate versus early removal of UC in patients undergoing MICR. The investigators hypothesize that immediate UC removal is non-inferior to 24-h UC removal in terms of AUR rate. Randomization is at the patient level and participants are randomized 1:1 to remove their UC either immediately or within 24 h from the completion of surgery. Those eligible for inclusion were patients undergoing any MICR with an anastomosis above the peritoneal reflection. Those patients who need to continue urinary output monitoring after the surgery will be excluded. The number of patients calculated to be enrolled in each group is 108 based on an expected AUR rate of 3% for the 24-h UC removal group and considering acceptable an AUR of 9% for the immediate UC removal group. Discussion: The demonstration of a non-inferiority of immediate versus 24-h removal of UC would call into question the usefulness of urinary drainage in the setting of MICR. Trial registration: ClinicalTrials.gov NCT05249192. Prospectively registered on February 21, 2022.

1 February 2020 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
Giulia TurriGiulia Turri
Giulia Turri
Corrado PedrazzaniCorrado Pedrazzani
Corrado Pedrazzani
MTMarzia Tripepi
Marzia Tripepi
FSFederica Secci
Federica Secci
MRMatteo Rivelli
Matteo Rivelli
AGAlfredo Guglielmi
Alfredo Guglielmi

15 June 2023 in Journal of Minimally Invasive Surgery
Verified
Journal Article
Open access
PDF file
MRMatteo Rivelli
Matteo Rivelli
Giulia TurriGiulia Turri
Giulia Turri
CCCristian Conti
Cristian Conti
AVAlessandro Valdegamberi
Alessandro Valdegamberi
Corrado PedrazzaniCorrado Pedrazzani
Corrado Pedrazzani
Matteo Rivelli, Giulia Turri, Cristian Conti, Alessandro Valdegamberi, Corrado Pedrazzani. Journal of Minimally Invasive Surgery 2023;26:93-5. https://doi.org/10.7602/jmis.2023.26.2.93